ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Mediplantex National Pharmaceutical JSC ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-8.98%
EBIT Growth (5y)
-9.91%
EBIT to Interest (avg)
3.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
1.05
Tax Ratio
21.62%
Dividend Payout Ratio
98.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.88%
ROE (avg)
4.86%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
0.87
EV to EBIT
16.83
EV to EBITDA
12.72
EV to Capital Employed
0.88
EV to Sales
0.80
PEG Ratio
NA
Dividend Yield
5.31%
ROCE (Latest)
5.21%
ROE (Latest)
3.62%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -38.88% (YoY
-25What is not working for the Company
NET PROFIT(HY)
At VND 5,221.84 MM has Grown at -40.28%
NET SALES(Q)
At VND 86,902.98 MM has Fallen at -16.02%
ROCE(HY)
Lowest at 3.54%
INTEREST(Q)
At VND 699.57 MM has Grown at 70.17%
CASH AND EQV(HY)
Lowest at VND 79,826.06 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.92%
Here's what is working for Mediplantex National Pharmaceutical JSC
Raw Material Cost
Fallen by -38.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Mediplantex National Pharmaceutical JSC
Net Profit
At VND 5,221.84 MM has Grown at -40.28%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (VND MM)
Net Sales
At VND 86,902.98 MM has Fallen at -16.02%
over average net sales of the previous four periods of VND 103,480.03 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (VND MM)
Interest
At VND 699.57 MM has Grown at 70.17%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
Cash and Eqv
Lowest at VND 79,826.06 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 2.92%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
